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Objectives: Mutations in GJB2 and MT-RNR1 are common causes for non-syndromic sensorineural
hearing loss (NSHL). In this study, we investigated the co-existence of both MT-RNR1 and bi-allelic GJB2
mutations in a large number of simplex and multiplex probands with NSHL.
Methods: 485 simplex and 134 multiplex probands with NSHL were recruited for mutation screening of
GJB2 and MT-RNR1 by bidirectional sequencing. Clinical features of probands with both MT-RNR1 and bi-
allelic GJB2 mutations were further analyzed in comparison with extended family members.
Results: MT-RNR1m.1555A>G and bi-allelic GJB2 mutations were both detected in one (0.21%) simplex
probands and two (1.49%) multiplex probands. Variable hearing phenotypes were found in a pair of
siblings with both MT-RNR1 and bi-allelic GJB2 mutations.
Conclusion: MT-RNR1 and bi-allelic GJB2 mutations may co-exist not only in multiplex probands but also
in simplex probands. The variable hearing phenotypes in closely-related family members may reﬂect the
co-existence of different molecular causes and prompt extended genetic tests.
 2014 Elsevier Ireland Ltd. 
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Hearing impairment (HI) is the most common sensory disorder
in humans. The prevalence of permanent sensorineural HI is up to
1.86% in newborns and 3.5% in adolescence [1]. It was estimated
that at least 50% to 60% of HI was caused by genetic factors [2].
Among them, approximately 70% are non-syndromic hearing loss
(NSHL), meaning the hearing impairment is the only distinctive
clinical feature, and the remaining 30% are syndromic hearing loss
(SHL) with other abnormalities [3].
Identifying the genetic basis of deafness provides crucial
information for diagnosis, intervention and treatment of the
disease. The genetic causes, however, are extremely heteroge-
neous. To date, mutations in more than 70 genes have been found
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of one NSHL gene is sufﬁcient to cause the disease.
GJB2 and MT-RNR1 were two common deafness genes that were
responsible for autosomal recessive and maternally-inherited
NSHL, respectively [1,4,5]. In many cases, genetic testing would
be considered complete when bi-allelic GJB2 mutations or a
pathogenic mutation in MT-RNR1 were identiﬁed. On the other
hand, due to the marked genetic heterogeneity of NSHL, mutations
in more than one causative gene may indeed co-exist within the
same proband as previously reported in isolated patients [6,7]. The
clinical features as well as the overall prevalence of such cases
among simplex and multiplex probands, however, were not well
studied. To this end, we performed a large scale mutation
screening of GJB2 and MT-RNR1 in 134 multiplex and 485 simplex
probands with NSHL in search for co-existence of pathogenic
mutations in both genes.
Materials and methods
Subjects and auditory evaluation
A total of 619 probands (485 simplex and 134 multiplex) with
NSHL >were recruited from deaf patients seeking genetic testing
and counseling in Xinhua Hospital, Shanghai, China. Clinical
information of the probands was summarized in Table 1. All
Table 1
Clinical characteristics of the probands.
Simplex probands
(n = 485)
Multiplex probands
(n = 134)
Sex
Male 273 61
Female 212 73
Age at the test
0–6 years 86 14
6–12 years 129 17
12–18 years 148 29
>18 years 122 74
Mean age (95% CI) 14.7 (13.7–15.6) 22.2 (19.8–24.6)
Severity of hearing impairment
Mild 3 4
Moderate 34 16
Serve 140 44
Profound 308 70
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family histories were consistent with either autosomal recessive or
maternally-inherited mode. All subjects and/or their parents gave
written, informed consent to participate in this study. This study
was approved by the Ethics Committee of Xinhua Hospital,
Shanghai Jiaotong University School of Medicine.
A complete medical history inquiry and detailed physical
examination was performed to exclude the possibility of syn-
dromic hearing impairment. Auditory evaluations were performed
including otoscopic examination, tympanometry, pure-tone audi-
ometry (PTA), and auditory brainstem response (ABR) in subjects
with very young age. Hearing thresholds of subjects were
determined by the air-conduction average thresholds at four
frequencies (0.5, 1, 2 and 4 kHz). All hearing thresholds reported in
this study were averages from the better ear. The severity of
hearing impairment was deﬁned as mild (20–40 dB), moderate
(41–70 dB), severe (71–95 dB) and profound (>95 dB). To enroll in
this study, all probands should have bilateral, permanent
sensorineural hearing impairment.
Mutational screening of GJB2 and MT-RNR1
Genomic DNA was extracted from the whole blood samples.
Mutation screening of GJB2 and MT-RNR1 was performed by PCR
ampliﬁcation and bidirectional sequencing as previously de-
scribed [8,9].
Results
Mutation screening of GJB2 and MT-RNR1 was performed in 485
simplex and 134 multiplex probands with bilateral NSHL. As
shown in Table 2, the prevalence of bi-allelic GJB2 mutations alone
was 18.8% (91/485) in simplex probands and 28.4% (38/134) in
multiplex probands. m.1555A>G was the only pathogenic muta-
tion identiﬁed for MT-RNR1. This mutation alone was identiﬁed in
2.3% (11/485) of simplex probands and 13.4% (18/134) of multiplex
probands. In the end, we identiﬁed two (1.5%) multiplex probandsTable 2
Mutation screening results of MT-RNR1 and GJB2 mutations.
Number (%) of probands
Simplex
(n = 485)
Multiplex
(n = 134)
Total
(n = 619)
Bi-allelic GJB2 mutations only 91 (18.8%) 38 (28.4%) 129 (20.8%)
MT-RNR1mutation only 11 (2.3%) 18 (13.4%) 29 (4.7%)
Co-existence of MT-RNR1 and
bi-allelic GJB2 mutations
1 (0.2%) 2 (1.5%) 3 (0.5%)and one (0.2%) simplex probands indeed carrying both MT-RNR1
and bi-allelic GJB2 mutations. For the 129 probands with bi-allelic
GJB2 mutations alone, profound hearing loss is the most prevalent
hearing phenotype (65.1%, 84/129), followed by severe hearing
loss (22.5%, 29/129), moderate hearing loss (10.9%, 14/129) and
mild hearing loss (1.6%, 2/129). For the 29 probands with MT-
RNR1m.1555A>G mutation alone, profound, severe and moderate
hearing loss accounted for 31.0% (9/29), 58.6% (17/29) and 10.3%
(3/29), respectively.
The pedigrees and audiograms of these three probands and
their family members were shown in Fig. 1. In Family 1, the
proband III-1 and his younger brother III-2 carried both MT-
RNR1m.1555A>G and GJB2 p.V63L/p.M195V compound heterozy-
gous mutations; his mother II-2 carried a single heterozygous
p.V63L mutation in GJB2 and a m.1555A>G mutation in MT-RNR1;
his aunt II-3 and two cousins III-3 and III-4 carried only a
m.1555A>G mutation in MT-RNR1. Auditory evaluations showed
that III-1 had moderate HI (PTA: 44 dB HL) while III-2 had a much
severe HI (PTA: 95 dB HL). The hearing phenotype of III-3 was
similar to that of III-2. Individuals II-2, II-3 and III-4 had normal
hearing in spite of carrying the m.1555A>G mutation in MT-RNR1.
Medical history showed that only III-2 and III-3, had used
gentamicin and/or streptomycin in the past.
In Family 2, the proband II-1 carried both MT-RNR1m.1555A>G
and GJB2 c.235delC homozygous mutations; his mother I-2 carried
a heterozygous c.235delC mutation in GJB2 and an m.1555A>G
mutation in MT-RNR1; his father I-1 carried homozygous c.235delC
mutation in GJB2. Individuals II-1 (PTA: 104 dB HL) and I-1 (PTA:
107 dB HL) were both profoundly deaf, while the HI of I-2 (PTA:
79 dB HL) was much milder. Individual II-1 had exposure history of
aminoglycosides. Medical histories of I-1 and I-2 were not
available.
In Family 3, the proband carried both MT-RNR1m.1555A>G and
GJB2 c.235delC homozygous mutations and had profound HI (PTA:
110 dB HL). Four family members, I-2, II-2, II-3 and II-4 carried MT-
RNR1m.1555A>G mutation but had normal hearing. No history of
exposure to aminoglycosides was recorded in any member of this
family.
Discussion
In mainland China, bi-allelic GJB2 mutations and MT-RNR
mutations were reported in 18.9% and 3.7% of patients with NSHL,
respectively [5]. Based on these percentages, co-existence of MT-
RNR1 and bi-allelic GJB2 mutations was expected to be present in
approximate 0.7% (18.9%  3.7%) of patients. This is consistent
with our ﬁnding that that MT-RNR1 and bi-allelic GJB2 mutations
co-existed in 3 out of 619 Chinese Han probands (0.5%) with NSHL.
Interestingly, due to the incomplete penetrance of the MT-RNR1
mutations, in many cases closely related to the exposure history of
aminoglycosides, we identiﬁed both MT-RNR1 and bi-allelic GJB2
mutations not only in multiplex probands but also in a simplex
proband with NSHL. Our results suggested that genetic testing of
all common deafness genes should be completed in spite of the
intermediate testing results, especially for those with less number
of exons that can be screened in relative ease.
In this study, we also observed variable hearing phenotypes in
Family 1 and 2 that segregated with separate or co-existent MT-
RNR1 and bi-allelic GJB2 mutations. Though intrafamilial pheno-
typic variation may be attributed to many factors such as
interactions between genetic and environmental factors, modiﬁer
genes, differential gene expression, alternative splicing, mutations
in regulatory regions or a broad spectrum of phenotypes associated
with a single genetic cause, in at least some cases it may help us to
speculate on the co-existence of multiple pathogenic causes in a
family.
Fig. 1. Pedigrees and audiograms of the three families with MT-RNR1 and GJB2 mutations.
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tion of GJB2 p.V63L/p.M195V compound heterozygous mutations
identiﬁed in Family 1. Reports of those two variants were rare and
the pathogenesis associated with them remained unclear. Based on
our data and previous results, we speculated that this genotype
likely contributed to the pathogenesis of moderate HI: (1) these
two variants were found in a compound heterozygous state in a
patient with moderate hearing loss (Fig. 1). Though this proband
also carried an MT-RNR1m.1555A>G mutation, he had no history
of exposure to aminoglycosides; (2) another compound heterozy-
gous mutations of GJB2, p.M195V/c.176_191del16bp, has been
previously reported to lead to moderate HI in a Japanese patient
[10]; (3) those two variants changed two highly conserved residues
of connexin 26; (4) they were not detected in 400 ethnically-
matched normal hearing controls (data not shown). Alternatively,
these two variants might be a rare polymorphism and thesepatients may simply be coincidental carrier whose deafness is
caused by other factors other than p.M195V and p.V63L. So, the
conclusive pathogenicity of these two variants should be further
studied.
In summary, we showed that a small, but notable percentage of
probands with NSHL carries both MT-RNR1 and bi-allelic GJB2
mutations. For more accurate and complete genetic testing and
counseling, mutation screening of all common deafness genes
should be completed in spite of the intermediate testing results.
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